GSK shares fell more than 5% after U.S. health officials narrowed their recommendation of respiratory syncytial virus vaccines to a smaller age range and more at-risk patients.
Related Posts
Norfolk Southern’s CEO Survived an Activist Attack. Then Came Talk of an Affair.
Alan Shaw was fired after a board investigation found that he and the legal chief had a romantic relationship.
Harley Will Ride or Die With the Graybeards
Milwaukee-based company focuses on high-end motorcycles, but some say it isn’t cultivating the next generation of buyers. ’You get older, you actually realize it’s a […]
Musk Shows Off Driverless Robotaxi to Be Priced Under $30,000
The electric-car maker also unveiled a second vehicle, a Robovan, designed to shuttle up to 20 people at a time.